For clinics offering both services, objective body composition tracking helps patients see the complete story of their transformationnot just the number on the scale
Among firms with 10 to 199 workers that do not offer health benefits, 9% offered funds to one or more of their employees to purchase non-group coverage, a similar percentage (11%) as last year [Figure 2.11]
The combinations of Semaglutide/Cilofexor/Firsocostat (Novo Nordisk and Gilead), Tropifexor/CVC (Allergan and Novartis) and Selonsertib/Cilofexor/Firsocostat (Gilead, now discontinued) have all been discussed in more detail above
Melanotan II Research MT-2 Research Peptide Research Use Only Melanotan II Research Applications Melanotan II has been referenced in laboratory research involving melanocortin peptide studies, receptor biology, peptide signaling pathways, molecular biology, cellular communication, and experimental peptide models
Scientific References Wessells H et al
By 2025, only about 19% of companies with 200 or more workers were covering GLP-1s for weight loss